← FDA Drug Approvals (Drugs@FDA)

ERYTHROMYCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SENTISS · Approved 1996-07-18

Drug application

FDA Application #

ANDA064030

Application type

Abbreviated New Drug Application (Generic)

Brand name

ERYTHROMYCIN

Generic name

ERYTHROMYCIN

Active ingredients

ERYTHROMYCIN

Dosage form

OINTMENT

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

SENTISS

Manufacturer

Sentiss Pharmaceuticals LLC

First approval

1996-07-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown